Article
Targeting posttranslational modifications of RioK1 inhibits the progression of colorectal…
bioRxiv · 2017 · Xuehui Hong
Key facts
| Title | Targeting posttranslational modifications of RioK1 inhibits the progression of colorectal and gastric cancers |
|---|---|
| First author | Xuehui Hong |
| Journal | bioRxiv |
| Published | Aug 1, 2017 |
| DOI | 10.1101/171058 |
| Devices mentioned | K011853, K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967 and 25 more |
| Product codes mentioned | DEW, DHR, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, JJX and 3 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1